Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705)

Hunan Jiudian Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	499.56	425.05	345.84	398.41	135.26	131.58
Trading Asset Securities	150.8	90.29	90.26	100.31	-	-
Cash & Short-Term Investments	650.36	515.34	436.1	498.72	135.26	131.58
Cash Growth	65.30%	18.17%	-12.56%	268.72%	2.80%	-22.85%
Accounts Receivable	508.64	625.76	503.58	284.9	189.5	148.03
Other Receivables	4.48	0.38	0.49	2.15	1.03	0.96
Receivables	513.12	626.14	504.07	287.05	190.52	148.99
Inventory	320.03	265.53	241.04	214.48	153.12	136.4
Other Current Assets	29.21	22.95	25.28	20.03	24.71	37.21
Total Current Assets	1,513	1,430	1,206	1,020	503.6	454.18
Property, Plant & Equipment	1,215	1,141	892.29	606.83	533.15	535.64
Long-Term Investments	86.41	30	30	-	-	-
Other Intangible Assets	86.99	88.82	91.66	77.36	51.06	52.14
Long-Term Deferred Tax Assets	51.73	66.29	43.25	29.19	17.85	14.86
Long-Term Deferred Charges	30.96	27.69	10.73	3.16	2.77	3.43
Other Long-Term Assets	83.45	87.47	25.29	8.43	22.29	11.85
Total Assets	3,068	2,871	2,300	1,745	1,131	1,072
Accounts Payable	155.05	159.29	143.8	108.88	59.91	69.35
Accrued Expenses	49.99	80.59	85.84	47.27	36.04	25.17
Short-Term Debt	36.04	51.85	71.57	53.77	10.4	65
Current Portion of Long-Term Debt	10.69	5.95	13.12	50.54	7.52	6.43
Current Portion of Leases	0.11	0.11	0.11	-	-	-
Current Income Taxes Payable	2.29	8.92	0.69	7.73	2.74	1.74
Current Unearned Revenue	31.59	37.27	72.25	57.41	42.16	-
Other Current Liabilities	93.71	71.58	56.97	44.79	22.2	32.85
Total Current Liabilities	379.45	415.56	444.34	370.38	180.96	200.54
Long-Term Debt	359.44	332.48	231.49	224.28	70.5	68.72
Long-Term Leases	-	0.05	0.15	-	-	-
Long-Term Unearned Revenue	145.64	145.37	65.52	51.25	43.58	40.96
Long-Term Deferred Tax Liabilities	4.7	4.47	5.59	-	-	-
Total Liabilities	889.23	897.93	747.09	645.9	295.04	310.23
Common Stock	486.53	345.15	342.94	234.69	234.68	234.68
Additional Paid-In Capital	419.7	529.9	484.87	278.97	278.79	278.79
Retained Earnings	1,185	1,012	724.82	516.37	322.22	248.4
Comprensive Income & Other	86.66	86.08	-	69.31	-	-
Total Common Equity	2,178	1,973	1,553	1,099	835.68	761.87
Shareholders' Equity	2,178	1,973	1,553	1,099	835.68	761.87
Total Liabilities & Equity	3,068	2,871	2,300	1,745	1,131	1,072
Total Debt	406.27	390.44	316.44	328.58	88.42	140.16
Net Cash (Debt)	244.09	124.9	119.66	170.14	46.83	-8.58
Net Cash Growth	575.06%	4.38%	-29.67%	263.28%	-	-
Net Cash Per Share	0.51	0.26	0.26	0.37	0.10	-0.02
Filing Date Shares Outstanding	486.53	483.2	480.11	459.99	459.97	459.97
Total Common Shares Outstanding	486.53	483.2	480.11	459.99	459.97	459.97
Working Capital	1,133	1,014	762.15	649.9	322.64	253.63
Book Value Per Share	4.48	4.08	3.23	2.39	1.82	1.66
Tangible Book Value	2,091	1,884	1,461	1,022	784.62	709.73
Tangible Book Value Per Share	4.30	3.90	3.04	2.22	1.71	1.54
Buildings	935.24	909.22	459.58	458.26	405.68	408.14
Machinery	563.88	459.5	359.41	316.06	245.82	229.13
Construction In Progress	49.74	69.32	308.14	18.16	24.88	2.07

Source: S&P Capital IQ. Standard template. Financial Sources.